224 related articles for article (PubMed ID: 25952368)
1. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy.
Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY
Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368
[TBL] [Abstract][Full Text] [Related]
2. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study.
Ren H; Wu C; Shao Y; Liu S; Zhou Y; Wang Q
Front Med; 2020 Oct; 14(5):642-650. PubMed ID: 31950345
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of hypoxia inducible Factor-1α in patients with diabetic nephropathy.
Wang J; Ye S
Niger J Clin Pract; 2019 Jun; 22(6):750-753. PubMed ID: 31187757
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of lipoprotein-associated phospholipase A2 in early diabetic nephropathy.
Zhai Y; Cao X; Liu S; Shen Y
Ann Med; 2023; 55(2):2230446. PubMed ID: 37566692
[TBL] [Abstract][Full Text] [Related]
5. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios.
Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q
J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304
[TBL] [Abstract][Full Text] [Related]
6. Triglyceride-glucose index: A surrogate marker of homeostasis model assessment of insulin resistance to predict diabetic nephropathy.
Khan S; Qayyum S; Khan MNA
J Pak Med Assoc; 2024 May; 74(5):862-867. PubMed ID: 38783431
[TBL] [Abstract][Full Text] [Related]
7. New risk factors in diabetic nephropathy: microRNA-196-3p and microRNA-203.
Eroglu İ; Korkmaz H; Ozturk KH; Sirin FB; Sevik S; Afsar B
Minerva Endocrinol (Torino); 2022 Sep; 47(3):314-324. PubMed ID: 33331738
[TBL] [Abstract][Full Text] [Related]
8. Serum chromogranin A correlated with albuminuria in diabetic patients and is associated with early diabetic nephropathy.
Yu H; Wang H; Su X; Cao A; Yao X; Wang Y; Zhu B; Wang H; Fang J
BMC Nephrol; 2022 Jan; 23(1):41. PubMed ID: 35062888
[TBL] [Abstract][Full Text] [Related]
9. Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease.
Ren H; Shao Y; Ma X; An L; Liu Y; Wang Q
Arch Physiol Biochem; 2024 Jun; 130(3):285-299. PubMed ID: 35147479
[TBL] [Abstract][Full Text] [Related]
10. The correlation of serum musclin with diabetic nephropathy.
Zhang J; Shi J; Cheng Z; Hu W
Cytokine; 2023 Jul; 167():156211. PubMed ID: 37137178
[TBL] [Abstract][Full Text] [Related]
11. Decreased serum myonectin concentrations in diabetic nephropathy patients.
Zhang J; Hu W; Lin P; Wang R
Clin Exp Med; 2020 Nov; 20(4):601-607. PubMed ID: 32852729
[TBL] [Abstract][Full Text] [Related]
12. Regulatory mechanism of TGF-β1/SGK1 pathway in tubulointerstitial fibrosis of diabetic nephropathy.
Miao XJ; Bi TT; Tang JM; Lv R; Gui DK; Yang XF
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10482-10488. PubMed ID: 31841202
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D and Hypoxia-Inducible Factor (HIF-1α) Serum Levels as Markers for Progression of Nephropathy in Type 2 Diabetic Patients.
Gharib AF; Askary AE; Almehmadi M; Etewa RL; Althobaiti BB; Allam HH; Elsayyad LK; Shafie A
Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443576
[TBL] [Abstract][Full Text] [Related]
14. Expression Level of Circulating Cell Free miR-155 Gene in Serum of Patients with Diabetic Nephropathy.
Akhbari M; Khalili M; Shahrabi-Farahani M; Biglari A; Bandarian F
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414764
[TBL] [Abstract][Full Text] [Related]
15. Higher Serum Asprosin Level is Associated with Urinary Albumin Excretion and Renal Function in Type 2 Diabetes.
Deng X; Zhao L; Guo C; Yang L; Wang D; Li Y; Xia H; Wang C; Cai Z; Li L; Zhao Z; Yuan G
Diabetes Metab Syndr Obes; 2020; 13():4341-4351. PubMed ID: 33223841
[TBL] [Abstract][Full Text] [Related]
16. Sodium Bicarbonate Supplementation and Urinary TGF-
Raphael KL; Greene T; Wei G; Bullshoe T; Tuttle K; Cheung AK; Beddhu S
Clin J Am Soc Nephrol; 2020 Feb; 15(2):200-208. PubMed ID: 31974286
[TBL] [Abstract][Full Text] [Related]
17. Microalbuminuria, Other Markers of Nephropathy and Biochemical Derangementsin Type 2 Diabetes Mellitus: Relationships and Determinants.
Idowu AA; Ajose AO; Adedeji AT; Adegoke AO; Jimoh KA
Ghana Med J; 2017 Jun; 51(2):56-63. PubMed ID: 28955101
[TBL] [Abstract][Full Text] [Related]
18. Serum Irisin and Diabetic Nephropathy in Patients with Diabetes Mellitus.
Kawada T
Horm Metab Res; 2021 Dec; 53(12):825. PubMed ID: 34891213
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
[TBL] [Abstract][Full Text] [Related]
20. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients.
Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y
Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
